CTT Pharmaceutical CTTH Stock
CTT Pharmaceutical Price Chart
CTT Pharmaceutical CTTH Financial and Trading Overview
| CTT Pharmaceutical stock price | 0.07 USD |
| Previous Close | 0.0085 USD |
| Open | 0.0085 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0085 - 0.0085 USD |
| 52 Week Range | 0.0085 - 0.07 USD |
| Volume | 975 USD |
| Avg. Volume | 16.49K USD |
| Market Cap | 18.97M USD |
| Beta (5Y Monthly) | 0.982042 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CTTH Valuation Measures
| Enterprise Value | 236.97K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.24285716 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
CTT Pharmaceutical Stock Price History
| Beta (5Y Monthly) | 0.982042 |
| 52-Week Change | -87.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 USD |
| 52 Week Low | 0.0085 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
CTTH Share Statistics
| Avg. Volume (3 month) | 16.49K USD |
| Avg. Daily Volume (10-Days) | 850 USD |
| Shares Outstanding | 21.32M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2014 |
| Most Recent Quarter (mrq) | September 30, 2015 |
| Next Fiscal Year End | December 31, 2015 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -153.56% |
| Return on Equity (ttm) | -448.83% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1670159 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 32.12K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 87.62K USD |
| Total Debt/Equity (mrq) | 11.87 USD |
| Current Ratio (mrq) | 5.012 |
| Book Value Per Share (mrq) | 0.035 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -131174 USD |
| Levered Free Cash Flow (ttm) | -216976 USD |
Profile of CTT Pharmaceutical
| Country | United States |
| State | ON |
| City | Ottawa |
| Address | 429 Kent Street unit 112 |
| ZIP | K2P 2B4 |
| Phone | 613-241-9959 |
| Website | https://www.cttpharmaceuticals.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.
Q&A For CTT Pharmaceutical Stock
What is a current CTTH stock price?
CTT Pharmaceutical CTTH stock price today per share is 0.07 USD.
How to purchase CTT Pharmaceutical stock?
You can buy CTTH shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CTT Pharmaceutical?
The stock symbol or ticker of CTT Pharmaceutical is CTTH.
Which industry does the CTT Pharmaceutical company belong to?
The CTT Pharmaceutical industry is Drug Manufacturers-Specialty & Generic.
How many shares does CTT Pharmaceutical have in circulation?
The max supply of CTT Pharmaceutical shares is 51.07M.
What is CTT Pharmaceutical Price to Earnings Ratio (PE Ratio)?
CTT Pharmaceutical PE Ratio is now.
What was CTT Pharmaceutical earnings per share over the trailing 12 months (TTM)?
CTT Pharmaceutical EPS is -0.01 USD over the trailing 12 months.
Which sector does the CTT Pharmaceutical company belong to?
The CTT Pharmaceutical sector is Healthcare.